このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Human Tendon Tissue Collection

2026年5月18日 更新者:Queen Mary University of London

Human Tendon Tissue Collection for In Vitro Models and Tissue Analysis

The goal of this study is to improve understanding of tendon health and disease by using surplus tendon tissue that is routinely removed during planned orthopaedic surgeries in adults. The main questions it aims to answer are:

- What can tendon tissue and tendon cells tell us about how healthy and diseased tendons function?

Participants will not undergo any extra procedures. Instead, researchers will use only tissue that is already being removed as part of normal surgical care and would otherwise be discarded.

Participants will:

  • Be asked for permission (consent) before their surgery to donate any surplus tendon tissue.
  • Have a small piece of tendon tissue (normally waste material) collected during their planned operation.
  • Allow the research team to access some non-identifiable medical information (such as age, reason for surgery, and relevant medical history) to help interpret research findings.

What the researchers will do with the donated tissue:

  • Isolate different types of human tendon cells.
  • Build advanced laboratory cellular models to study how tendon diseases develop.
  • Analyse whole tendon tissue sections to understand cell types, tissue organisation, and disease-related changes.

This study does not involve testing treatments, and it does not change any aspect of a participant's clinical care. Although there is no direct benefit to participants, the donated tissue may help researchers develop better ways to study tendon injuries and improve future treatment options for tendon disease.

調査の概要

状態

まだ募集していません

詳細な説明

This study aims to improve our understanding of how human tendons work, why they become injured, and how tendon diseases develop. Tendon problems-such as tendinopathy-are common and can cause long-lasting pain and loss of mobility. Scientists currently lack good laboratory models that accurately represent real human tendon tissue, which makes it harder to study these conditions or test new treatments.

During many types of planned orthopaedic surgery, small pieces of tendon tissue are routinely removed because they are no longer needed for the patient's care. Normally, this tissue would simply be thrown away. In this study, patients who are already having surgery are invited to donate this surplus tissue for research.

How the study works:

If a patient agrees to take part, the healthcare team will collect the leftover tendon tissue during their planned operation. There are no extra procedures, no changes to the surgery, and nothing additional that the patient needs to do.

After collection, the tissue is taken to research laboratories at Queen Mary University of London. There, scientists use it in two main ways:

  1. Studying the tendon tissue itself:

    Researchers examine the structure and cells within the tendon to study how tendon cells are organised.

  2. Growing tendon cells in the lab:

The donated tissue allows researchers to isolate living tendon cells. These cells can then be used to build more advanced laboratory models-such as "tendon-on-a-chip" systems-that mimic how tendons experience movement, load, and interaction with other cell types. These models will help scientists study disease processes and could support the development of new treatments in the future.

To support this work, the research team also receives a small amount of non-identifiable medical information about each donor-such as age, general health information, and the reason for surgery. This helps researchers understand how different factors may influence tendon biology. All personal details (like names or NHS numbers) remain within the hospital and are never shared with the research team.

Why this research matters:

Human tendon tissue is rarely available for research, yet it is essential for creating accurate models and understanding real-world disease. By using tissue that would otherwise be discarded, this study will:

  • Provide new insights into how tendons function and how tendon diseases develop.
  • Help researchers design more realistic laboratory systems to study tendon conditions.
  • Support future work aiming to improve diagnosis, prevention, and treatment of tendon disorders.

Although participants will not directly benefit, their donated tissue may contribute to scientific progress that improves care for people with tendon injuries in the future.

研究の種類

観察的

入学 (推定)

400

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

サンプリング方法

非確率サンプル

調査対象母集団

Patients scheduled to undergo orthopaedic lower limb surgery at the Royal London, Whipps Cross University Hospital and the Barts Health Orthopaedic Centre in Newham.

説明

Inclusion Criteria:

  • 18 years or older
  • Scheduled to undergo orthopaedic lower limb surgery that involve tendon tissue waste
  • Have provided informed consent to take part in the study

Exclusion Criteria:

  • Under the age of 18
  • Unable or unwilling to give informed consent (including those with limited English proficiency)
  • Cases where tendon tissue is required for clinical care and therefore not surplus.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Obtain sufficient tendon tissue samples.
時間枠:Perioperative to immediate post-collection laboratory processing (within 24 hours).
The main outcome of this project is to obtain sufficient tendon tissue to isolate different human tendon cells and perform tissue analysis.
Perioperative to immediate post-collection laboratory processing (within 24 hours).

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Hazel Screen, Professor, PhD、Queen Mary University of London

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年6月1日

一次修了 (推定)

2031年6月1日

研究の完了 (推定)

2031年6月1日

試験登録日

最初に提出

2026年4月1日

QC基準を満たした最初の提出物

2026年5月18日

最初の投稿 (実際)

2026年5月26日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月26日

QC基準を満たした最後の更新が送信されました

2026年5月18日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

キーワード

その他の研究ID番号

  • 368295

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

No individual participant data will be shared. All data used in the study are pseudonymised before transfer to the research team, and identifiable information remains within the NHS clinical environment. No IPD dataset suitable for external sharing will be generated.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する